Search results for: 'spending on Information Technology in Europe'

HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and discussions with industry leaders, a consistent me...

The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical device industries. What started in the late 1990s as a...

This report offers a forward-looking analysis of the consumer wellness landscape through 2030 by examining how rapid technological progress, evolving consumer expectations, and cross-industry convergence are reshaping wellness into a data-driven and highly personalized ecosystem. It revolves around the shift from reactive care toward proactive, pre...

23 Jun 2017  |  Global  |  Market Research

Blockchain Technology in Global Healthcare, 2017–2025

Healthcare Industry Assesses Blockchain Potential to Optimize Healthcare Workflows and Improve Outcome-based Care Delivery Models

Infographics

×

Blockchain technology, with its ubiquitous security infrastructure for seamless health data exchange, holds potential to eliminate the burden and cost of health data reconciliation and facilitate interoperability. Emerging blockchain systems promise to unlock new economic advantages by disintermediating high-cost gatekeepers and automating transact...

This study examines how global multiomics technologies are changing the way that cancer is treated, with a focus on new developments, strategic needs, and future directions. By facilitating thorough tumor characterization, early detection, patient stratification, and real-time monitoring, multiomics—an integrated analysis of genomics, transcriptomi...

This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

Healthcare systems today are facing a convergence of pressures that threaten both operational stability and patient outcomes. Workforce shortages, clinician burnout, rising costs, and persistent health inequities are compounded by the growing demands of an aging population with complex needs.These challenges are not isolated—they interact and inten...

The focus of this report is on clinical-grade remote patient monitoring (RPM). RPM is a digital solution that involves secure transmission of medical data collected on devices, via information and communication technologies, through text, sound, images or other forms needed for the prevention, diagnosis, treatment and follow-up of patients. Health ...